on Apr 19, 2018
PPAG is pleased to announced new Fellows in the Pediatric Pharmacy Advocacy Group (FPPAG). The Fellows program recognizes pediatric pharmacists who distringuish themselves in the profession and demonstrate sustained practice excellence, contribute to the total body of knowledge, educate and mentor future members of the profession, and demonstrate active leadership in professional activities.
Jared Cash, PharmD, MBA, BCPS, FPPAG
Jared Cash is the Director of Pharmacy at Intermountain Healthcare’s Primary Children’s Hospital is Salt Lake City, UT. He is also an adjunct Assistant Professor at the University of Utah College of Pharmacy. He received his Bachelors of Pharmacy from the University of Utah in 1996 and his Doctor of Pharmacy from the University of Florida in 1996. Dr. Cash is a Board Certified Pharmacotherapy Specialist. He recently completed a Masters of Business Administration. During his 26 years at Primary Children’s Hospital he has been a Pediatric Intensive Care Pharmacist, PALS instructor, Pediatric Intensive Care Team Leader, Clinical Coordinator, and a Pharmacy Manager. Dr. Cash served on the PPAG Board of Directors from 2011-2017, as President in 2015-2016.
David Knoppert, BScPh, FPPAG
David Knoppert completed a Degree in Honors Biology in 1976, then a Bachleor's Degree in Education in 1977. He graduated with a BScPhm from the University of Toronto in 1980, then completed a Hospital Residency in London, Ontario during 1980-81. In 2004 he completed a MSc degree in Clinical Epidemiology at Western University. From 1981 to 1983 he was a staff pharmacist at The Hospital for Sick Children in Toronto. In 1986 Mr. Knoppert completed a MScPhm at The University of Toronto. 1986 he began as an NICU Pharmacist and Drug Information Pharmacist at St Joseph's Hospital in London, ON. In 1989 he became the Clinical Coordinator, and continued to practice in the NICU. In 2011 Mr. Knoppert followed the Perinatal Program Transfer to London Health Sciences Centre where he became the Pediatric Clinical Coordinator and Residency Coordinator until he retired in November of 2013. In 2014 he became a part time Coordinator for Pharmacy Students from the University of Waterloo. At that time he also joined the Board for the Canadian Council on Continuing Education in Pharmacy (CCCEP). He continues to be a Board member of the International Alliance for Better Medicines in Children (IABMC). Mr. Knoppert served at President of PPAG in 2011-12 during his term on the Board between 2008-13.
Jamie Miller, PharmD, BCPS, BCPPS, FPPAG
Jamie Miller is an Associate Professor in the Department of Pharmacy Clinical and Administrative Sciences at the University of Oklahoma College of Pharmacy and Adjunct Associate Professor of Pediatrics at the OU College of Medicine. Dr. Miller currently practices as a Clinical Pharmacy Specialist in the Neonatal Intensive Care Unit at the Children’s Hospital at OU Medical Center in Oklahoma City. In addition, Dr. Miller is the Residency Program Director for the PGY1 Pharmacy Residency at the University of Oklahoma College of Pharmacy and OU Medical Center. Dr. Miller received her Doctor of Pharmacy degree from Southwestern Oklahoma State University College of Pharmacy. Following graduation, she completed a PGY1 Pharmacy Residency and PGY2 Pediatric Pharmacy Residency at the University of Oklahoma College of Pharmacy and OU Medical Center. Among her professional affiliations, she is a member of the Pediatric Pharmacy Advocacy Group, American Society of Health-System Pharmacists, and American Association of Colleges of Pharmacy. Her research/scholarship focuses on sedation/analgesia and drug withdrawal in critically-ill neonates, infants, and children.
Katherine Pham, PharmD, FPPAG
Kathy Pham, PharmD is the Director of Policy and Professional Affairs at the American College of Clinical Pharmacy. Her career path as taken an interesting turn from clinical practice to advocacy to public policy work. Her clinical career started after receiving her BSPharm and Pharm.D. degrees from Rutgers, the State University of NJ. She then completed a Pharmacy Practice Residency with Emphasis in Pediatrics at the University of Illinois at Chicago. She went on to teach as Assistant Professor of Pharmacy Practice at Long Island University. She further developed her pediatric clinical practice at St Joseph's Children's Hospital in NJ before her 8 year career at Children's National Medical Center, where she was the NICU Clinical Specialist as well as the Residency Program Director of the PGY1 Pharmacy and PGY2 Pediatric Pharmacy Residency programs. She became Board-certified in Pediatric Pharmacotherapy in 2017. She then pursued a unique opportunity as the Senior Officer of the Drug Safety Project at the Pew Charitable Trusts before recently joining ACCP at the start of 2018.
Hanna Phan, PharmD, FPPAG
Dr. Hanna Phan is an Associate Professor in Pharmacy Practice and Science at the College of Pharmacy and in the Department of Pediatrics at the College of Medicine at the University of Arizona (UA). She is also an Associate Research Scientist for the UA Asthma and Airway Disease Research Center and Faculty for the UA Pediatric Pulmonary Center (PPC). Dr. Phan practices as a Clinical Pharmacy Specialist in Pediatric Pulmonary Medicine at Banner University Medical Center-Tucson, practicing in both Pediatric Pulmonary Clinics and the Adult CF center. She established the Post-Graduate Year 2 (PGY-2) Pediatric Pharmacy Residency at Banner University Medical Center–Tucson, Diamond Children’s in 2009 and served as Residency Program Director through 2015. Dr. Phan earned her Doctor of Pharmacy (PharmD) from the University of Michigan and completed a Postdoctoral Fellowship in Pediatric Pharmacotherapy at The Ohio State University. Dr. Phan has received state and national recognition for her clinical practice, professional service, and research from organizations such as the Arizona Pharmacy Association, Pediatric Pharmacy Advocacy Group (PPAG), American College of Clinical Pharmacy (ACCP), and the American Society of Health-System Pharmacists (ASHP) Foundation. She was a Director-at-Large on the PPAG board from 2014-2017 and has previously chaired the PPAG Research Committee (2013-2014) and is currently a Co-Chair for the PPAG Recertification Advisory Committee. She has given invited lectures nationally and internationally, and authored various book chapters and peer-reviewed manuscripts in the area of pediatric pharmacotherapy. Dr. Phan’s current research interests include patient-caregiver education and medication adherence, pediatric medication safety, and interprofessional care of children with chronic conditions such as cystic fibrosis and asthma.